report | Pharmaceuticals & Medical ProductsAlthough Japan is now the second-largest pharmaceutical market, most MNCs have yet to capture the full opportunity set. Recently, however, the industry has hit on a new alliance strategy for MNC originators that want to operate in Japan—the reverse co-promotion.